Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease

European Journal of Haematology

Volumn 91, Issue 1, 2013, Pages 62-68

  Paul, Rabindra ^a   Minniti, Caterina P ^b   Nouraie, Mehdi ^a   Luchtman Jones, Lori ^c   Campbell, Andrew ^d   Rana, Sohail ^a   Onyekwere, Onyinye ^a   Darbari, Deepika S ^b,c   Ajayi, Olaid ^a   Arteta, Manuel ^d   Ensing, Gregory ^d   Sable, Craig ^c   Dham, Niti ^c   Kato, Gregory J ^b   Gladwin, Mark T ^e   Castro, Oswaldo L ^a   Gordeuk, Victor R ^f  

^a HOWARD UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Acute chest syndrome; Asthma; Pain; Sickle cell disease; Vaso occlusive crisis

Indexed keywords

HYDROXYUREA;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ARTICLE; ASTHMA; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PAIN; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCHOOL CHILD; SICKLE CELL; SICKLE CELL ANEMIA; TRICUSPID VALVE REGURGITATION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANOXIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEMOGLOBIN, SICKLE; HUMANS; LUNG DISEASES; MALE; REGRESSION ANALYSIS; RISK FACTORS; TIME FACTORS; VASCULAR DISEASES; YOUNG ADULT;

EID: 84879459386     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12118     Document Type: Article

References (38)

1. Ballas SK, Lieff S, Benjamin LJ, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol 2010;85:6-13.
2. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-9.
3. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine 1988;67:66-76.
4. Gray A, Anionwu EN, Davies SC, Brozovic M. Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol 1991;44:459-63.
5. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
6. Quinn CT, Shull EP, Ahmad N, Lee NJ, Rogers ZR, Buchanan GR. Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia. Blood 2007;109:40-5.
7. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342:1855-65.
8. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997;89:1787-92.
9. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007;7:91-6.
10. Graham LM. Sickle cell disease: pulmonary management options. Pediatr Pulmonol Suppl 2004;26:191-3.
11. Telen MJ. Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. Hematology Am Soc Hematol Educ Program 2007;7:84-90.
12. Araujo JG, Araujo-Melo CA, de Menezes-Neto OA, da Silveira DF, Correia JB, Cipolotti R. Risk factors for acute chest syndrome in patients from low socioeconomic background: a cohort study from Sergipe, Brazil. J Pediatr Hematol Oncol 2011;33:421-3.
13. Minniti CP, Sable C, Campbell A, et al. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica 2009;94:340-7.
14. Ensing G, Seward J, Darragh R, Caldwell R. Feasibility of generating hemodynamic pressure curves from noninvasive Doppler echocardiographic signals. J Am Coll Cardiol 1994;23:434-42.
15. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, Pignatelli RH, Rychik J. Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 2006;19:1413-30.
16. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-84.
17. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood 2006;108:2923-7.
18. Poulter EY, Truszkowski P, Thompson AA, Liem RI. Acute chest syndrome is associated with history of asthma in hemoglobin SC disease. Pediatr Blood Cancer 2011;57:289-93.
19. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease. Lung 2010;188:499-504.
20. Anim SO, Strunk RC, DeBaun MR. Asthma morbidity and treatment in children with sickle cell disease. Expert Rev Respir Med 2011;5:635-45.
21. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005;60:206-10.
22. Nordness ME, Lynn J, Zacharisen MC, Scott PJ, Kelly KJ. Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clin Mol Allergy 2005;3:2.
23. Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med Overseas Ed 1995;333:699-703.
24. Gelfand MJ, Daya SA, Rucknagel DL, Kalinyak KA, Paltiel HJ. Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome. J Nucl Med 1993;34:614-8.
25. Kopecky EA, Jacobson S, Joshi P, Koren G. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clin Pharmacol Ther 2004;75:140-6.
26. Sprinkle RH, Cole T, Smith S, Buchanan GR. Acute chest syndrome in children with sickle cell disease. A retrospective analysis of 100 hospitalized cases. Am J Pediatr Hematol Oncol 1986;8:105-10.
27. Chaudry RA, Cikes M, Karu T, Hutchinson C, Ball S, Sutherland G, Rosenthal M, Bush A, Crowley S. Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance. Arch Dis Child 2011;96:131-6.
28. Ambrusko SJ, Gunawardena S, Sakara A, Windsor B, Lanford L, Michelson P, Krishnamurti L. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatr Blood Cancer 2006;47:907-13.
29. Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease. Pediatrics 2008;121:777-82.
30. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350:886-95.
31. Mekontso Dessap A, Leon R, Habibi A, et al. Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 2008;177:646-53.
32. Forrest S, Kim A, Carbonella J, Pashankar F. Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease. Pediatr Blood Cancer 2012;58:937-40.
33. Anthi A, Machado RF, Jison ML, et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med 2007;175:1272-9.
34. Gordeuk VR, Minniti CP, Nouraie M, et al. Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia. Haematologica 2011;96:33-40.
35. Santoli F, Zerah F, Vasile N, Bachir D, Galacteros F, Atlan G. Pulmonary function in sickle cell disease with or without acute chest syndrome. Eur Respir J 1998;12:1124-9.
36. Fanconi S, Kraemer R, Weber J, Tschaeppeler H, Pfenninger J. Long-term sequelae in children surviving adult respiratory distress syndrome. J Pediatr 1985;106:218-22.
37. Dahlem R, de Jongh FHC, Griffioen RW, Bos AP, van Aalderen WMC. Respirator sequelae after acute hypoxemic respiratory failure in children with meningococcal septic shock. Crit Care Shock 2004;7:20-6.
38. Fertrin KY, Costa FF. Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment. Expert Rev Hematol 2010;3:443-58.